• Skip to primary navigation
  • Skip to main content
  • Skip to footer
ARVC Studies

ARVC Studies

  • About ARVC
    • Overview
    • Causes
    • Symptoms
    • Diagnosis
  • Gene Therapy for ARVC
    • Basic Genetics
    • Mutations & Disease
    • Gene Therapy
    • AAV Capsids
    • TN-401 for ARVC
  • Our Studies
    • RIDGE-1
    • RIDGE
  • Resources
  • Contact Us
Resources

Share this page:

For more information about Tenaya’s clinical programs, complete this form or contact Wendy on our Patient Advocacy team by email or phone at (650) 825-6990 option 4.

Wendy Borsari, Associate Director of Patient Advocacy, Living with genetic HCM, community advocate for over a decade

Resources

ARVC

The following community organizations offer information and resources to individuals and families affected by ARVC:

  • Sudden Arrhythmia Death Syndrome Foundation (SADS)
  • The Johns Hopkins Precision Medicine Center of Excellence for ARVC
  • American Heart Association (AHA)
  • Cardiomyopathy UK
  • Children’s Cardiomyopathy Foundation (CCF)
  • Italian Association for the Study and Research of Cardiomyopathies (AICARM)
  • Global Heart Hub (GHH)
  • Genetic Cardiomyopathy Awareness Consortium

Gene Therapy

Find more information about gene therapy:

  • American Society of Gene & Cell Therapy (ASGCT)
  • HealingGenes
  • Global Genes
  • MedlinePlus Genetics
  • National Human Genome Research Institute
  • National Organization for Rare Disorders (NORD)

Clinical Trial Participation

Visit the resources below to learn more about taking part in clinical research:

  • The Center for Information and Study on Clinical Research Participation
    • Learn the basics about clinical trials
    • Questions to ask the study staff
    • Resources
  • U.S. Department of Health and Human Services
    • About research participation
  • National Institutes of Health
    • NIH clinical research trials and you
  • ClinicalTrials.gov
    • Learn about clinical studies
  • U.S. Food & Drug Administration
    • The drug development process

Tenaya Therapeutics

Find more information about Tenaya Therapeutics

    • Information for patients and families
    • Tenaya’s publications on gene therapy research for genetic heart conditions

 

Contact Us

For more information about Tenaya’s clinical programs, complete this form or contact our Patient Advocacy team by email or phone at (650) 825-6990 option 4.

Address

Tenaya Therapeutics, Inc.
171 Oyster Point Blvd., Suite 500
South San Francisco, CA 94080

Website

tenayatherapeutics.com

Email Address

patient.advocacy@tenayathera.com
clinical.trials@tenayathera.com

Footer

  • X formerly twitter
  • LinkedIn
  • Facebook
  • Instagram

This website is a service of Tenaya Therapeutics, Inc., a clinical-stage biotechnology company committed to a bold mission: to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease.

  • Expanded Access Policy
  • Privacy Policy
  • Cookie Policy
  • Terms & Conditions
  • Community Guidelines

© 2024 Tenaya Therapeutics. All rights reserved
Last Updated November 25, 2024